Here is a recent tweet...nice! Jennifer Buell @jbuell01...3 hours ago $AGEN hits 2018 milestones w AGEN1181 (nex-gen CTLA-4) FDA safe to proceed to clinic + IND filed for AGEN1223 (first-in-class intratumoral Treg depleting Bispecific). So far, 5 INDs in 2018 & one more on its way (AGEN1423). #immunoOncology #patientcare
Let's hope for a nice Santa Claus Rally next week!